Skip to main content
Top
Published in: Diabetologia 11/2019

Open Access 01-11-2019 | Obesity | Article

Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity

Authors: Leon G. Straub, Vissarion Efthymiou, Gerald Grandl, Miroslav Balaz, Tenagne Delessa Challa, Luca Truscello, Carla Horvath, Caroline Moser, Yael Rachamin, Myrtha Arnold, Wenfei Sun, Salvatore Modica, Christian Wolfrum

Published in: Diabetologia | Issue 11/2019

Login to get access

Abstract

Aims/hypothesis

In the context of diabetes, the health benefit of antioxidant treatment has been widely debated. In this study, we investigated the effect of antioxidant treatment during the development of insulin resistance and hyperphagia in obesity and partial lipodystrophy.

Methods

We studied the role of antioxidants in the regulation of insulin resistance using the tamoxifen-inducible fat-specific insulin receptor knockout (iFIRKO) mouse model, which allowed us to analyse the antioxidant’s effect in a time-resolved manner. In addition, leptin-deficient ob/ob mice were used as a hyperphagic, chronically obese and diabetic mouse model to validate the beneficial effect of antioxidants on metabolism.

Results

Acute induction of insulin receptor knockout in adipocytes changed the substrate preference to fat before induction of a diabetic phenotype including hyperinsulinaemia and hyperglycaemia. In healthy chow-fed animals as well as in morbidly obese mice, this diabetic phase could be reversed within a few weeks. Furthermore, after the induction of insulin receptor knockout in mature adipocytes, iFIRKO mice were protected from subsequent obesity development through high-fat diet feeding. By genetic tracing we show that the persistent fat mass loss in mice after insulin receptor knockout in adipocytes is not caused by the depletion of adipocytes. Treatment of iFIRKO mice with antioxidants postponed and reduced hyperglycaemia by increasing insulin sensitivity. In ob/ob mice, antioxidants rescued both hyperglycaemia and hyperphagia.

Conclusions/interpretation

We conclude that fat mass reduction through insulin resistance in adipocytes is not reversible. Furthermore, it seems unlikely that adipocytes undergo apoptosis during the process of extreme lipolysis, as a consequence of insulin resistance. Antioxidants have a beneficial health effect not only during the acute phase of diabetes development, but also in a temporary fashion once chronic obesity and diabetes have been established.
Appendix
Available only for authorised users
Literature
15.
go back to reference Yancy WS, Dunbar SA, Boucher JL et al (2014) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013 36:3821–3842 RESPONSE. Diabetes Care 37(5): E102-E103. 10.2337/dc14-0077 Yancy WS, Dunbar SA, Boucher JL et al (2014) Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2013 36:3821–3842 RESPONSE. Diabetes Care 37(5): E102-E103. 10.2337/dc14-0077
31.
go back to reference Djukanovic V, Mach EP, WHO, UNICEF (1975) Alternative approaches to meeting basic health needs in developing countries: a joint UNICEF/WHO study. WHO, Geneva Djukanovic V, Mach EP, WHO, UNICEF (1975) Alternative approaches to meeting basic health needs in developing countries: a joint UNICEF/WHO study. WHO, Geneva
36.
go back to reference Perchellet EM, Maatta EA, Abney NL, Perchellet JP (1987) Effects of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-O-tetradecanoylphorbol-13-acetate. J Cell Physiol 131(1):64–73. https://doi.org/10.1002/jcp.1041310111 CrossRefPubMed Perchellet EM, Maatta EA, Abney NL, Perchellet JP (1987) Effects of diverse intracellular thiol delivery agents on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-O-tetradecanoylphorbol-13-acetate. J Cell Physiol 131(1):64–73. https://​doi.​org/​10.​1002/​jcp.​1041310111 CrossRefPubMed
43.
go back to reference Heumueller S, Schreiber JG, Scholich K, Brandes RP (2009) Apocynin is activated by several peroxidases. Free Radical Bio Med 47:S143–S144 Heumueller S, Schreiber JG, Scholich K, Brandes RP (2009) Apocynin is activated by several peroxidases. Free Radical Bio Med 47:S143–S144
Metadata
Title
Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity
Authors
Leon G. Straub
Vissarion Efthymiou
Gerald Grandl
Miroslav Balaz
Tenagne Delessa Challa
Luca Truscello
Carla Horvath
Caroline Moser
Yael Rachamin
Myrtha Arnold
Wenfei Sun
Salvatore Modica
Christian Wolfrum
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-019-4937-7

Other articles of this Issue 11/2019

Diabetologia 11/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.